Mankind Pharma Ltd (MANKIND) — Cash Flow Quality Index
Mankind Pharma Ltd (MANKIND) has a Cash Flow Quality Index of 0.48x as of December 2023. Operating cash flow of Rs2.19 Billion is below net income of Rs4.54 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore Mankind Pharma Ltd operating cash flow efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Mankind Pharma Ltd Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Mankind Pharma Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check total reinvestment intensity of Mankind Pharma Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Mankind Pharma Ltd (2019–2025)
Year-by-year earnings quality comparison for Mankind Pharma Ltd. For live market cap and the full company financial profile, see how much is Mankind Pharma Ltd worth.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.21x | Rs24.13 Billion | Rs19.91 Billion | ▲ +7.7% |
| 2024 | 1.13x | Rs21.52 Billion | Rs19.13 Billion | ▼ -20.5% |
| 2023 | 1.41x | Rs18.13 Billion | Rs12.82 Billion | ▲ +203.7% |
| 2022 | 0.47x | Rs9.20 Billion | Rs19.75 Billion | ▼ -30.7% |
| 2021 | 0.67x | Rs11.37 Billion | Rs16.92 Billion | ▼ -9.6% |
| 2020 | 0.74x | Rs10.70 Billion | Rs14.38 Billion | ▼ -28.3% |
| 2019 | 1.04x | Rs6.00 Billion | Rs5.79 Billion | — |